Uploaded May 2026 | Updated September 2026, 2 weeks ago
Zélia Gouveia, Head of Process Development at CellAction, shares how the QX700 S Droplet Digital PCR system has become essential for characterizing CAR-T and other cell-based therapies as they advance from R&D toward clinical use. With highly sensitive detection from minimal DNA input and fast, absolute quantification without the need for standard curves, this system removes variability seen with qPCR and delivers more reliable results. She highlights the simplicity of the workflow, moving from sample loading to results within hours, as well as the power of multiplexing to measure multiple parameters at once.
Everything your lab needs. All in one place. The QX700 Family.
Meet the Next Evolution of Digital PCR: bio-rad.com/CellAction
Subscribe to Bio-Rad for the latest breakthroughs in life science research and clinical diagnostics.
#LifeSciences #ClinicalDiagnostics #Biotech
Zélia Gouveia, Head of Process Development at CellAction, shares how the QX700 S Droplet Digital PCR system has become essential for characterizing CAR-T and other cell-based therapies as they advance from R&D toward clinical use. With highly sensitive detection from minimal DNA input and fast, absolute quantification without the need for standard curves, this system removes variability seen with qPCR and delivers more reliable results. She highlights the simplicity of the workflow, moving from sample loading to results within hours, as well as the power of multiplexing to measure multiple parameters at once.
Everything your lab needs. All in one place. The QX700 Family.
Meet the Next Evolution of Digital PCR: bio-rad.com/CellAction
Subscribe to Bio-Rad for the latest breakthroughs in life science research and clinical diagnostics.
#LifeSciences #ClinicalDiagnostics #Biotech
